12 West Capital Management LP 10x Genomics, Inc. Transaction History

12 West Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$36.95 - $82.41 $46.9 Million - $105 Million	-1,268,854 Reduced 50.38%	1,249,646 $56.5 Million
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $28.7 Million - $75 Million	514,500 Added 25.67%	2,518,500 $192 Million
Q4 2021 Feb 14, 2022	BUY	$135.05 - $182.59 $11.1 Million - $15 Million	82,000 Added 4.27%	2,004,000 $299 Million
Q3 2020 Nov 16, 2020	BUY	$87.44 - $125.0 $42.6 Million - $60.9 Million	487,000 Added 33.94%	1,922,000 $240 Million
Q2 2020 Aug 14, 2020	BUY	$58.39 - $89.31 $83.8 Million - $128 Million	1,435,000 New	1,435,000 $128 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of 12 West Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on 12 West Capital Management LP with notifications on news.